These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1176187)

  • 1. Disruption of isolated peritoneal mast cells of the rat by human serum and that by other species.
    Marshall R
    Int Arch Allergy Appl Immunol; 1975; 49(5):647-57. PubMed ID: 1176187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the lytic effect of guinea pig complement by rabbit complement.
    Kempf RA; Gigli I; Austen KF
    J Immunol; 1969 Apr; 102(4):795-803. PubMed ID: 5768190
    [No Abstract]   [Full Text] [Related]  

  • 3. An explanation for the inefficiency of guinea pig complement in the cytolysis of sheep erythrocytes or rat mast cells sensitized with rabbit antiserum: a double block.
    Kempf RA; Gigli I; Austen KF
    Transplant Proc; 1969 Mar; 1(1):626-8. PubMed ID: 4109231
    [No Abstract]   [Full Text] [Related]  

  • 4. Activation of human complement by rat peritoneal mast cells and its inhibition by a rat serum factor.
    Arizono N; Nishimukai H; Nakao S; Takeoka O
    Agents Actions; 1988 Jun; 24(1-2):73-9. PubMed ID: 3136626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative studies on the haemolytic and Treponema pallidum immobilizing complement activity in the serum of different species.
    Müller F; Segerling M
    Immunology; 1970 Jan; 18(1):13-8. PubMed ID: 4983520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histamine release, formation of prostaglandin-like activity (SRS-C) and mast cell degranulation by the direct lytic factor (DLF) and phospholipase A of cobra venom.
    Damerau B; Lege L; Oldigs HD; Vogt W
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287(2):141-56. PubMed ID: 49854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release of histamine from sensitized rat peritoneal cells by specific and unspecific antigens.
    Norn S
    Acta Pharmacol Toxicol (Copenh); 1967; 25(4):456-60. PubMed ID: 4170091
    [No Abstract]   [Full Text] [Related]  

  • 8. Alternate complement pathway in porcine sera: lysis of guinea pig erythrocytes.
    Renshaw HW; Gilmore RJ
    Comp Immunol Microbiol Infect Dis; 1980; 3(4):473-84. PubMed ID: 7471719
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemolysis of sheep erythrocytes in guinea pig serum deficient in the fourth component of complement. II. Evidence for involvement of C1 and components of the alternate complement pathway.
    May JE; Frank MM
    J Immunol; 1973 Dec; 111(6):1668-76. PubMed ID: 4750863
    [No Abstract]   [Full Text] [Related]  

  • 10. Ability to activate the alternative complement pathway acquired by human and guinea-pig erythrocytes after contact with influenza virus.
    Lambré C; Thibon M
    Ann Immunol (Paris); 1980; 131C(2):213-21. PubMed ID: 7416718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum accessory factors in the measurement of arbovirus neutralization reactions.
    Way HJ; Garwes DJ
    J Gen Virol; 1970 Jun; 7(3):211-23. PubMed ID: 4989506
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of species of origin of red blood cells on in vitro inhibition of streptolysis O by serum lipoproteins.
    Hamnström B; Winblad S
    Int Arch Allergy Appl Immunol; 1972; 42(4):590-5. PubMed ID: 5063918
    [No Abstract]   [Full Text] [Related]  

  • 13. Specificity of C3 receptors that mediate phagocytosis by rat peritoneal mast cells.
    Vranian G; Conrad DH; Ruddy S
    J Immunol; 1981 Jun; 126(6):2302-6. PubMed ID: 6971894
    [No Abstract]   [Full Text] [Related]  

  • 14. Complement "specificity" and interchangeability: measurement of hemolytic complement levels and use of the complement-fixation test with sera from common domesticated animals.
    Grant CK
    Am J Vet Res; 1977 Oct; 38(10):1611-7. PubMed ID: 337860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of human anaphylatoxin C3a with rat mast cells demonstrated by immunofluorescence.
    ter Laan B; Molenaar JL; Feltkamp-Vroom TM; Pondman KW
    Eur J Immunol; 1974 May; 4(5):393-5. PubMed ID: 4136830
    [No Abstract]   [Full Text] [Related]  

  • 16. Receptors for C3 on rat peritoneal mast cells.
    Sher A; McIntyre SL
    J Immunol; 1977 Aug; 119(2):722-5. PubMed ID: 407303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaphylactic hyposensitization of rat mast cells in vitro by antigen.
    Norn S; Skov PS
    Clin Exp Immunol; 1974 Nov; 18(3):431-7. PubMed ID: 4143305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of human reagins with rat peritoneal mast cells by histamine release.
    Vijayanagar HM; Attallah NA; David MF; Sehon AH
    Int Arch Allergy Appl Immunol; 1974; 46(3):375-92. PubMed ID: 4138181
    [No Abstract]   [Full Text] [Related]  

  • 19. Formation of slow-reacting substance by guinea pig immunoglobulins.
    Jancar S; Akimura OK; Dias da Silva W
    Am J Pathol; 1976 Dec; 85(3):531-48. PubMed ID: 11696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The release of pharmacologically active substances during antigen-antibody reaction in the rat peritoneal cavity.
    Marquis VO
    Afr J Med Sci; 1973 Jan; 4(1):23-9. PubMed ID: 4121188
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.